Literature DB >> 19498072

Invited Commentary: Assessing treatment effects by using observational analyses--opportunities and limitations.

Philip S Wang1, Michael Schoenbaum.   

Abstract

Making decisions about medical treatments based upon valid evidence is critical to improve health-care quality, outcomes, and value. Although such research commonly connotes the use of randomized controlled trials, experimental methods are not always feasible, and research using observational, quasi-experimental, and other nonexperimental methods may also be important. At the same time, nonexperimental methods are inherently susceptible to various types of bias and thus present special challenges in the search for valid and generalizable evidence. The study by Gardarsdottir et al. (Am J Epidemiol. 2009;170(3):280-285), on which this commentary is based, addresses a key potential source of bias -- mismeasurement of patients' duration of treatment -- in previous research on pharmacotherapy for depression. However, the authors' study is unlikely to address other potential sources of bias, which may make interpretation of their findings more difficult.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498072      PMCID: PMC2727173          DOI: 10.1093/aje/kwp137

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression.

Authors:  A J Claxton; Z Li; J McKendrick
Journal:  Br J Psychiatry       Date:  2000-08       Impact factor: 9.319

2.  Improving mental health treatments through comparative effectiveness research.

Authors:  Philip S Wang; Christine M Ulbricht; Michael Schoenbaum
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

3.  The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

Authors:  C A Melfi; A J Chawla; T W Croghan; M P Hanna; S Kennedy; K Sredl
Journal:  Arch Gen Psychiatry       Date:  1998-12

4.  Determinants of antidepressant treatment outcome.

Authors:  N Sood; M Treglia; R L Obenchain; B Dulisse; C A Melfi; T W Croghan
Journal:  Am J Manag Care       Date:  2000-12       Impact factor: 2.229

5.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

Authors:  H A Pincus; T L Tanielian; S C Marcus; M Olfson; D A Zarin; J Thompson; J Magno Zito
Journal:  JAMA       Date:  1998-02-18       Impact factor: 56.272

Review 6.  A framework to improve the quality of treatment for depression in primary care.

Authors:  Thomas W Croghan; Michael Schoenbaum; Cathy D Sherbourne; Paul Koegel
Journal:  Psychiatr Serv       Date:  2006-05       Impact factor: 3.084

7.  Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias.

Authors:  Helga Gardarsdottir; Toine C Egberts; Joost J Stolker; Eibert R Heerdink
Journal:  Am J Epidemiol       Date:  2009-06-04       Impact factor: 4.897

  7 in total
  1 in total

1.  Association is not causation: treatment effects cannot be estimated from observational data in heart failure.

Authors:  Christopher J Rush; Ross T Campbell; Pardeep S Jhund; Mark C Petrie; John J V McMurray
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.